Grove Bank & Trust Novartis Ag Transaction History
Grove Bank & Trust
- $622 Million
- Q2 2024
A detailed history of Grove Bank & Trust transactions in Novartis Ag stock. As of the latest transaction made, Grove Bank & Trust holds 891 shares of NVS stock, worth $101,449. This represents 0.02% of its overall portfolio holdings.
Number of Shares
891
Previous 910
2.09%
Holding current value
$101,449
Previous $88,000
6.82%
% of portfolio
0.02%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,427Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.39 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.39 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$844 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$843 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$677 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $245B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...